学术探索
学术期刊
学术作者
新闻热点
数据分析
智能评审

Fibrinolytic and inflammatory markers for arterial occlusion: The evolving epidemiology of thrombosis and hemostasis

被引：5
作者：
Ridker, PM
机构：
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年 / 78卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 [临床医学]; 100201 [内科学];
摘要：
引用
收藏
页码：53 / 59
页数：7
相关论文
共 86 条
[1]
RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY [J].
ALFTHAN, G ;
PEKKANEN, J ;
JAUHIAINEN, M ;
PITKANIEMI, J ;
KARVONEN, M ;
TUOMILEHTO, J ;
SALONEN, JT ;
EHNHOLM, C .
ATHEROSCLEROSIS, 1994, 106 (01) :9-19
[2]
SERUM TOTAL HOMOCYSTEINE AND CORONARY HEART-DISEASE [J].
ARNESEN, E ;
REFSUM, H ;
BONAA, KH ;
UELAND, PM ;
FORDE, OH ;
NORDREHAUG, JE .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (04) :704-709
[3]
BAKER MT, 1996, CIRCULATION, V94, P460
[4]
C-REACTIVE PROTEIN-LEVELS AS A DIRECT INDICATOR OF INTERLEUKIN-6 LEVELS IN HUMANS INVIVO [J].
BATAILLE, R ;
KLEIN, B .
ARTHRITIS AND RHEUMATISM, 1992, 35 (08) :982-983
[5]
ELEVATION OF C-REACTIVE PROTEIN IN ACTIVE CORONARY-ARTERY DISEASE [J].
BERK, BC ;
WEINTRAUB, WS ;
ALEXANDER, RW .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (03) :168-172
[6]
A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[7]
SERUM AMYLOID-A PROTEIN IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION [J].
CASL, MT ;
SURINA, B ;
GLOJNARICSPASIC, I ;
PAPE, E ;
JAGARINEC, N ;
KRANJCEVIC, S .
ANNALS OF CLINICAL BIOCHEMISTRY, 1995, 32 :196-200
[8]
INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY [J].
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
MUSSONI, L ;
DONATI, MB ;
CARDILLO, M ;
CATALANO, M ;
GABRIELLI, L ;
LOMBARDI, B ;
SPECCHIA, G ;
TAVAZZI, L ;
TREMOLI, E ;
POZZOLI, E ;
TURRI, M ;
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
CARDILLO, M ;
TORRI, M ;
RAINISIO, M ;
GENTILE, G ;
MOREO, G ;
BIANCHI, O ;
LEONARDI, P ;
COLOMBI, M ;
CATALANO, M ;
GALIMBERTI, P ;
RUSSO, U ;
CRESSOTTI, A ;
CARZANIGA, G ;
NOBILI, S ;
NINNO, D ;
DONATI, MB ;
IACOVIELLO, L ;
DEGAETANO, G ;
GABRIELLI, L ;
MARTELLI, E ;
CORSI, G ;
LORENZI, G ;
LOMBARDI, B ;
CARRIERO, MR ;
COLOMBO, R ;
SPECCHIA, G ;
CIOFFI, P ;
SCIRE, A ;
TAVAZZI, L ;
GIANNUZZI, P ;
CORRA, U ;
TEMPORELLI, L ;
MORA, F .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10) :1412-1417
[9]
LIPOPROTEIN LP(A) AS PREDICTOR OF MYOCARDIAL-INFARCTION IN COMPARISON TO FIBRINOGEN - LDL CHOLESTEROL AND OTHER RISK-FACTORS - RESULTS FROM THE PROSPECTIVE GOTTINGEN RISK INCIDENCE AND PREVALENCE STUDY (GRIPS) [J].
CREMER, P ;
NAGEL, D ;
LABROT, B ;
MANN, H ;
MUCHE, R ;
ELSTER, H ;
SEIDEL, D .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (07) :444-453
[10]
DAWSON SJ, 1993, J BIOL CHEM, V268, P10739
123456789